The Patent Finder

ActiveSite Pharmaceuticals, Inc.

Also on record
Records under this name other than the patents ActiveSite Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 6 patents it holds.

Showing 1 to 4 of 4 · Back to ActiveSite Pharmaceuticals, Inc.

PatentTitleStatus Expires Confidence
US 11,306,061Crystalline Forms of Plasma Kallikrein Inhibitors
Formerly held
In force
 · High confidence
In forceHigh confidence
US 12,240,818Crystalline Forms of Plasma Kallikrein Inhibitors
Formerly held
In force
 · High confidence
In forceHigh confidence
US 8,691,861Prodrugs of inhibitors of plasma kallikrein
Lapsed on the fee record
Ended Apr 8, 2026 · From the USPTO record
Lapsed on the fee recordEnded Apr 8, 2026From the USPTO record
US 8,658,685Methods for treatment of kallikrein-related disorders
Formerly held
Lapsed on the fee record
Ended Feb 25, 2022 · From the USPTO record
Lapsed on the fee recordEnded Feb 25, 2022From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited